Amyloidosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Here, we show that absence of TYROBP/DAP12 in a mouse model of AD-type cerebral Aβ amyloidosis (APP<sup>KM670/671NL</sup>/PSEN1<sup>Δexon9</sup>) recapitulates the expected network characteristics by normalizing the transcriptome of APP/PSEN1 mice and repressing the induction of genes involved in the switch from homeostatic microglia to disease-associated microglia (DAM), including Trem2, complement (C1qa, C1qb, C1qc, and Itgax), Clec7a and Cst7.
|
30283032 |
2019 |
Neuralgia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Our results suggested that four differentially expressed genes, Jun, Gal, Cd74, and C1qb, had the potential to serve as prognostic or predictive markers for neuropathic pain, suggesting a potential application in the improvement of prognostic tools and treatments.
|
29331040 |
2018 |
Rett Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We identified over two hundred differentially expressed genes, and identified the complement C1Q complex genes (C1QA, C1QB and C1QC) as a point of convergence between gene expression changes in human and mouse Rett syndrome brain.
|
27267200 |
2016 |
CREST Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, complement genes (C1QC and C1QB) showed elevated expression in lcSSc without PAH, but were expressed at the low levels in lcSSc-PAH.
|
26669670 |
2015 |
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma.
|
21698244 |
2011 |
Amyotrophic Lateral Sclerosis, Sporadic
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
By Northern blot hybridization, SALS was associated with increased mRNA for C1qB and clusterin in the motor cortex (Brodmann area A4), but not in superior temporal cortex (A17), relative to neurologically normal controls.
|
10471215 |
1999 |
Recurrent infections
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased serum complement factor I
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ocular Hypertension
|
0.200 |
Biomarker
|
disease |
RGD |
Retinal synthesis and deposition of complement components induced by ocular hypertension.
|
16677633 |
2006 |
Retrograde Degeneration
|
0.200 |
Biomarker
|
phenotype |
RGD |
Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes.
|
16934480 |
2006 |
Liver Cirrhosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis.
|
26396155 |
2016 |
Fibrosis, Liver
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis.
|
26396155 |
2016 |
IGA Glomerulonephritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathy.
|
25133636 |
2014 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Corpus Luteum Cyst
|
0.300 |
Biomarker
|
disease |
CTD_human |
New insights into the pathogenesis of cystic follicles in cattle: microarray analysis of gene expression in granulosa cells.
|
21239663 |
2011 |
Ovarian Cysts
|
0.300 |
Biomarker
|
disease |
CTD_human |
New insights into the pathogenesis of cystic follicles in cattle: microarray analysis of gene expression in granulosa cells.
|
21239663 |
2011 |
Myocardial Ischemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cardioplegia prevents ischemia-induced transcriptional alterations of cytoprotective genes in rat hearts: a DNA microarray study.
|
16214533 |
2005 |
Complement deficiency disease
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
C1q regulatory region polymorphism down-regulating murine c1q protein levels with linkage to lupus nephritis.
|
12133956 |
2002 |
Antibody Deficiency Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.
|
2894352 |
1988 |
Immunologic Deficiency Syndromes
|
0.300 |
Biomarker
|
group |
CTD_human |
A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.
|
2894352 |
1988 |
Malignant neoplasm of breast
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Schizophrenia
|
0.310 |
Biomarker
|
disease |
PSYGENET |
The results obtained suggest that C1QB gene may be considered as a relevant candidate gene for susceptibility to schizophrenia, and its rs291982*G minor allele might represent a risk factor for schizophrenia at least in Armenian population.
|
21951915 |
2011 |
Schizophrenia
|
0.310 |
Biomarker
|
disease |
BEFREE |
The results obtained suggest that C1QB gene may be considered as a relevant candidate gene for susceptibility to schizophrenia, and its rs291982*G minor allele might represent a risk factor for schizophrenia at least in Armenian population.
|
21951915 |
2011 |
Lupus Erythematosus, Systemic
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Some of these SNPs affect multiple genes in trans that are known to be altered in individuals with disease: rs4917014, previously associated with systemic lupus erythematosus (SLE), altered gene expression of C1QB and five type I interferon response genes, both hallmarks of SLE.
|
24013639 |
2013 |
Lupus Erythematosus, Systemic
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Recent studies have tested genetic variation at the C1QA, C1QB and C1QC (complement component 1, q subcomponent, A chain, complement component 1, q subcomponent, B chain and complement component 1, q subcomponent, c chain) loci in relation to systemic lupus erythematosus (SLE) risk.
|
20528885 |
2010 |